小林製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 化学 | 4967/E01047 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2014/10/03 | 日証協 | 617,758株 | +4.33% | 222,512株 | +35.43% | 684,357株 | +5.13% | 62,984株 | -63.96% |
2014/09/26 | 日証協 | 592,107株 | +4.65% | 164,296株 | +68.11% | 650,991株 | +9.8% | 174,772株 | +273.8% |
2014/09/19 | 日証協 | 565,777株 | +0.93% | 97,732株 | +5.3% | 592,894株 | +0.52% | 46,756株 | +156.1% |
2014/09/12 | 日証協 | 560,589株 | -5.6% | 92,814株 | +29.44% | 589,850株 | -6.11% | 18,257株 | -71.2% |
2014/09/05 | 日証協 | 593,851株 | +0.49% | 71,707株 | -33.24% | 628,238株 | +1.87% | 63,400株 | +150.16% |
2014/08/29 | 日証協 | 590,929株 | -6.73% | 107,418株 | +74.95% | 616,717株 | -0.86% | 25,344株 | -55.77% |
2014/08/22 | 日証協 | 633,583株 | +1.29% | 61,398株 | -42.44% | 622,095株 | +3.25% | 57,300株 | +120.22% |
2014/08/15 | 日証協 | 625,483株 | -3.03% | 106,662株 | -27.67% | 602,495株 | -4.07% | 26,020株 | -62.83% |
2014/08/08 | 日証協 | 645,006株 | -5.52% | 147,463株 | -16.78% | 628,075株 | -4.33% | 70,001株 | +21.53% |
2014/08/01 | 日証協 | 682,706株 | +0.81% | 177,198株 | +45.83% | 656,474株 | +0.78% | 57,601株 | +31.51% |
2014/07/25 | 日証協 | 677,200株 | -0.31% | 121,508株 | +498.38% | 651,373株 | -3.12% | 43,801株 | +24.92% |
2014/07/18 | 日証協 | 679,321株 | -4.88% | 20,306株 | -71.35% | 672,370株 | -3.52% | 35,062株 | +137.85% |
2014/07/11 | 日証協 | 714,197株 | -3.62% | 70,872株 | -62.15% | 696,904株 | -4.95% | 14,741株 | -69.61% |
2014/07/04 | 日証協 | 741,021株 | -0.11% | 187,247株 | +248.61% | 733,163株 | +1.52% | 48,500株 | +99.38% |
2014/06/27 | 日証協 | 741,848株 | +2.55% | 53,713株 | -80.9% | 722,213株 | +0.61% | 24,326株 | -63.23% |
2014/06/20 | 日証協 | 723,377株 | +0.51% | 281,189株 | -4.36% | 717,857株 | -0.42% | 66,163株 | -48.83% |
2014/06/13 | 日証協 | 719,731株 | +8.98% | 294,017株 | +104.61% | 720,854株 | +6.16% | 129,304株 | +1.89% |
2014/06/06 | 日証協 | 660,395株 | +5.68% | 143,695株 | +6.33% | 679,052株 | +6.81% | 126,902株 | +92.27% |
2014/05/30 | 日証協 | 624,887株 | +6.38% | 135,137株 | -20.86% | 635,752株 | +5.13% | 66,002株 | +40.13% |
※株式分割は考慮していませんのでご注意ください。
Page Top